Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.
Sonpavde G, Manitz J, Gao C, Tayama D, Kaiser C, Hennessy D, Makari D, Gupta A, Abdullah SE, Niegisch G, Rosenberg JE, Bajorin DF, Grivas P, Apolo AB, Dreicer R, Hahn NM, Galsky MD, Necchi A, Srinivas S, Powles T, Choueiri TK, Pond GR.
Sonpavde G, et al. Among authors: gao c.
J Urol. 2020 Dec;204(6):1173-1179. doi: 10.1097/JU.0000000000001199. Epub 2020 Jun 18.
J Urol. 2020.
PMID: 32552295
Free PMC article.